- Home
- FDMT vs URG Comparison
FDMT vs URG Comparison
Compare FDMT & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | URG |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 608.7M |
| IPO Year | 2019 | 2006 |
Fundamental Metrics
Financial Performance| Metric | FDMT | URG |
|---|---|---|
| Price | $11.88 | $0.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $28.09 | $2.11 |
| AVG Volume (30 Days) | 971.2K | ★ 10.9M |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | $27,207,000.00 |
| Revenue This Year | N/A | $142.81 |
| Revenue Next Year | $55.65 | $80.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $6.96 | $0.79 |
| 52 Week High | $16.93 | $2.15 |
Technical Indicators
Market Signals| Indicator | FDMT | URG |
|---|---|---|
| Relative Strength Index (RSI) | 44.00 | 37.65 |
| Support Level | $8.68 | $0.79 |
| Resistance Level | $11.96 | $1.46 |
| Average True Range (ATR) | 0.94 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 44.43 | 37.59 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.